mershaw2001
I'm short the short sellers
NAVB is just absolutely dying. The funny thing is that their statement about expansion doesn't match their reported earnings, in other words, the money they got in is less than the adoption rate that they are claiming. That could be a good thing, in that the payments are delayed. However, I'll still probably dump about half my shares tomorrow to meet a margin call.Seems pretty typical for this stock lately. Whenever news comes out the stock goes down, good or bad. From the limited reading I did on the ER it looks like news is good other than the fact the Crede deal was dilutive and probably not the best move. They are burning through capital but they still have 25M on hand (technically 45M but 20M of that can't be touched). The really good news that came out of it was that they obtained an EU partner on Lymphoseek, which is what they have been waiting for recently.